| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2008 | EP1585529A4 Process for the production of 2'-branched nucleosides |
| 05/28/2008 | EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method |
| 05/28/2008 | EP1569650B1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/28/2008 | EP1554282B1 Morphinan derivatives substituted in position 14 and quaternary ammonium salts thereof, method for production and use thereof |
| 05/28/2008 | EP1546098B1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |
| 05/28/2008 | EP1537226B1 Method for reproducing pleuromutilins |
| 05/28/2008 | EP1537115B1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 05/28/2008 | EP1501507B1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1474412B1 Production of delta-9 tetrahydrocannabinol |
| 05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 05/28/2008 | EP1467769B1 Use of a resinate in the preparation of a formulation for smoking cessation |
| 05/28/2008 | EP1450773B1 Transdermal therapeutic system provided with improved long-term carrying comfort |
| 05/28/2008 | EP1438014B1 Oil-in-water emulsion containing non-polar active principles |
| 05/28/2008 | EP1424329B1 Process for the preparation of 4-(imidazol-1-yl)benzenesulfonamide derivatives |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1391194B1 Preparation for hair and/or scalp |
| 05/28/2008 | EP1381356B1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 05/28/2008 | EP1373260B1 Dibenzo c chromen-6-one derivatives as anti-cancer agents |
| 05/28/2008 | EP1370684B1 Polynucleotides related to colon cancer |
| 05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
| 05/28/2008 | EP1344526B1 Preventives/remedies for inflammatory airway diseases |
| 05/28/2008 | EP1343806B1 Methylene steroids as novel androgens |
| 05/28/2008 | EP1343483B1 Transdermal system containing a novel high potency progestagen |
| 05/28/2008 | EP1322595B1 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 05/28/2008 | EP1277471B1 Stable liquid preparation comprising sitafloxacin |
| 05/28/2008 | EP1263431B1 Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
| 05/28/2008 | EP1220675B1 Hormone-sensitive lipase activity mediated male infertility |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | EP1196587B1 Antigenic meningococcal peptides |
| 05/28/2008 | EP1165095B1 Agents for intravitreal administration to treat or prevent disorders of the eye |
| 05/28/2008 | EP1090127B1 Adh7 nucleotides |
| 05/28/2008 | EP1087752B1 Method for producing liposomal formulations of active agents |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | EP0886639B1 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES |
| 05/28/2008 | CN201064168Y Oligomeric proanhocyanidins microcapsule |
| 05/28/2008 | CN101189337A Ghrelin binding nucleic acids |
| 05/28/2008 | CN101189251A 17 beta-HSD1 and STS inhibitors |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189240A Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 05/28/2008 | CN101189239A Protein kinase inhibitors |
| 05/28/2008 | CN101189238A Piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189237A Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 05/28/2008 | CN101189236A Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 05/28/2008 | CN101189235A 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/28/2008 | CN101189234A Heterobicyclic inhibitors of HCV |
| 05/28/2008 | CN101189233A Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 05/28/2008 | CN101189232A 3-aryloxy-8-aza-bicyclo [3.2.1.] oct-6-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/28/2008 | CN101189231A Novel cyclic aminophenylalkanoic acid derivative |
| 05/28/2008 | CN101189230A Heterocyclic antiviral compounds |
| 05/28/2008 | CN101189229A Synthesis of avrainvillamide, stephacidin B, and analogues thereof |
| 05/28/2008 | CN101189228A Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors |
| 05/28/2008 | CN101189227A New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 05/28/2008 | CN101189226A Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists |
| 05/28/2008 | CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189224A Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenyl amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate |
| 05/28/2008 | CN101189223A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 05/28/2008 | CN101189222A Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 05/28/2008 | CN101189221A AMPA receptor potentiators |
| 05/28/2008 | CN101189219A Preventive or remedy for depression or anxiety neurosis |
| 05/28/2008 | CN101189218A Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |
| 05/28/2008 | CN101189217A Process for producing an aminomethyl thiazole compound |
| 05/28/2008 | CN101189216A Desferrithiocin polyether analogues |
| 05/28/2008 | CN101189215A Benzoxazocines and their therapeutic use |
| 05/28/2008 | CN101189211A Quinoline derivatives as NK3 anatgonists |
| 05/28/2008 | CN101189210A Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPTl) inhibitors |
| 05/28/2008 | CN101189209A C5a receptor antagonists |
| 05/28/2008 | CN101189208A 3-methanesulfonylquinolines as GABA-B enhancers |
| 05/28/2008 | CN101189044A Pharmaceutical composition containing an anti-fungus agent and one active substance selected from carveol, eugenol, thymol, borneol, carvacrol, alpha-ionone and beta-ionone |
| 05/28/2008 | CN101189043A Use of adrenergic alpha2B antagonists for the treatment of vasomotor symptoms |
| 05/28/2008 | CN101189016A Device and methods for treating paranasal sinus conditions |
| 05/28/2008 | CN101189015A 延长的雌激素定量给药避孕疗法 Prolonged estrogen therapy dosing contraceptive |
| 05/28/2008 | CN101189014A Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 05/28/2008 | CN101189013A Crystalline (2E,4S)-4-[(N-{[(2R)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-L-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and its pharmaceutical uses |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN101189011A Method of treating atherosclerosis, dyslipidemias and related conditions |
| 05/28/2008 | CN101189010A Tricyclic 6-alkylidene-penems as class-D bata-lactamases inhibitors |
| 05/28/2008 | CN101189009A Dermatological compositions and salts for the treatment of dermatological diseases |
| 05/28/2008 | CN101189008A Oxaprozin or closely related compound for the treatment and prevention of diseases |
| 05/28/2008 | CN101189007A Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 05/28/2008 | CN101189006A Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 05/28/2008 | CN101189005A Combinations of a squalene synthase inhibitor and a HMG-CoA reductase inhibitor for treating hyperlipidemia |
| 05/28/2008 | CN101189004A Treatment of pain |
| 05/28/2008 | CN101189003A Pharmaceutical formulations of HDAC inhibitors |
| 05/28/2008 | CN101189002A Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 05/28/2008 | CN101189000A Device for delivery of TRPV1 agonists |
| 05/28/2008 | CN101188999A A pharmaceutical delivery system for deliverying active component dispersed in dispersion medium |
| 05/28/2008 | CN101188996A Surface-modified microparticles and methods of forming and using the same |
| 05/28/2008 | CN101186936A Method for producing dry bacterium powder containing gamma-linolenic acid |
| 05/28/2008 | CN101186921A Novel gene Xsynuclein for xenopus laevis GRK family |
| 05/28/2008 | CN101186633A Saponin antimycotic compounds in holothuria scabra jaeger and preparation method thereof |
| 05/28/2008 | CN101186632A Method for preparing eleutheroside or aglycone thereof with anti-inflammatory action |
| 05/28/2008 | CN101186627A Method for preparing picroside I |